$12M capital infusion pumps Prairie Village-based Artio Medical to $46M in funding
April 29, 2021 | Startland News Staff
A Johnson County medical device company announced Thursday the closing of an additional $12 million tranche of Series A financing — advancing the startup’s tech toward clinical study and commercialization with the backing of a leading Kansas City real estate developer.
“We are thrilled to close this round of financing with strong support from existing investors who share our mission to provide better patient outcomes,” said Dr. F. Nicholas Franano, president and CEO of Artio. “The Artio team is focused on the road ahead as we advance multiple development programs and prepare for commercialization of our first product.”
The funding brings Artio’s total capital raised to $46 million, Franano said.
Click here to see why Artio Medical, formerly also known as Metactive, was named one of Startland News’ Kansas City Startups to Watch in 2019.
Led by existing investors Sarah Hagedorn and Nathaniel Hagedorn — founder and CEO of Northpoint Development — the deal announced Thursday will be used to accelerate the development of Artio’s peripheral vascular product pipeline, which is highly complementary with significant overlap in call points and procedures, the company said.
The Amplifi Vein Dilation System, which aims to prepare hemodialysis patients for successful vascular access site creation, has shown promising results in initial clinical testing, Artio said in a press release. And the Solus Gold Embolization Device comprises a low-profile, flexible catheter assembly and a non-porous, gold balloon-like implant and is designed for precise placement and immediate vessel occlusion. The device has shown exceptional performance in preclinical testing, the company said.
“Nick has built a broad, diverse portfolio of highly innovative products at Artio and is assembling a world-class team to develop and commercialize them,” said Nathaniel Hagedorn. “We were pleased to have the opportunity to lead this round of financing and to invest additional capital to move the company and its mission forward.”
Just over a year ago, Artio announced its rebranding from “Metactive” and a fresh $8.8 million round to help boost its best-in-class products for the peripheral vascular and neurovascular markets.
Click here to learn more about Artio Medical.
Featured Business
2021 Startups to Watch
stats here
Related Posts on Startland News
Fund Me, KC: ‘Scarlet Knight’ returns to inner city streets with a moral dilemma about abuse of power
Startland News is continuing its segment to highlight area entrepreneurs’ efforts to accelerate their businesses. This is an opportunity for entrepreneurs — like Juaquan Allen with his Scarlet Knight campaign — to share their crowdfunding stories to gain a little help from their supporters. Who are you? My name is Juaquan “Jay” Allen. I’m a…
Design by fire: Could a Kansas City company 3-D print the Notre Dame spire?
Beyond its status as the biggest in Kansas City, the impact of Dimensional Innovations’ new $2.2 million 3-D printer could reach globally — as the homegrown company considers ways it could help rebuild the historic spire atop the Notre Dame Cathedral, said Nate Borozinski. “This thing gives us an ability — and we think an…
Look inside: Fishtech Group opens its $10M+ Cyber Defense Center in Martin City
Fishtech Group is making a splash within the cyber security industry, showcasing its cloud-era capabilities in a new Cyber Defense Center that sits behind the gates of Fishtech’s sprawling Martin City campus, said Gary Fish. “I’ve been doing security since before it was cool,” said Fish, founder and CEO of Fishtech, as well as an…
Elite investors at exclusive CEO retreat: Don’t waste time; sell us on your billion-dollar idea
Trying to land the backing of a venture capital firm? Throw your pitch deck out the window, Chris Olsen advised a select group of Kansas City CEOs. “A lot of times founders will come and give us their pitch and they’ll start going through it and [they’re telling us] they’re profitable in 18-months. And we’ll…